...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: Wondering if volume will start picking back up Nov 16th approaches...

Consider next week volume may increase to cover shorts, if news is positive,  big days in following week, then will return to low volume, new holding pattern, waiting for news NDA submitted, then again, volume lowers, waiting for FDA approval.  All due to very low float.  On day FDA approves pps goes over the rainbow.  Good for all, patients and stockholders.

Share
New Message
Please login to post a reply